Correlation Between NeOnc Technologies and Phio Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both NeOnc Technologies and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeOnc Technologies and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeOnc Technologies Holdings, and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on NeOnc Technologies and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeOnc Technologies with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeOnc Technologies and Phio Pharmaceuticals.

Diversification Opportunities for NeOnc Technologies and Phio Pharmaceuticals

-0.19

Correlation Coefficient

NeOnc Technologies  Phio Pharmaceuticals

Good diversification

The 3 months correlation between NeOnc and Phio is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding NeOnc Technologies Holdings, and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and NeOnc Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeOnc Technologies Holdings, are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of NeOnc Technologies i.e., NeOnc Technologies and Phio Pharmaceuticals go up and down completely randomly.

Pair Corralation between NeOnc Technologies and Phio Pharmaceuticals

Given the investment horizon of 90 days NeOnc Technologies is expected to generate 2.63 times less return on investment than Phio Pharmaceuticals. In addition to that, NeOnc Technologies is 1.7 times more volatile than Phio Pharmaceuticals Corp. It trades about 0.01 of its total potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about 0.06 per unit of volatility. If you would invest  223.00  in Phio Pharmaceuticals Corp on April 24, 2025 and sell it today you would earn a total of  29.00  from holding Phio Pharmaceuticals Corp or generate 13.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NeOnc Technologies Holdings,  vs.  Phio Pharmaceuticals Corp

NeOnc Technologies

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NeOnc Technologies Holdings, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating technical indicators, NeOnc Technologies may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Phio Pharmaceuticals Corp

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeOnc Technologies and Phio Pharmaceuticals

The main advantage of trading using opposite NeOnc Technologies and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeOnc Technologies position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.

The idea behind NeOnc Technologies Holdings, and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.